EA029088B1 - Макроциклические и бициклические ингибиторы вируса гепатита c - Google Patents

Info

Publication number

EA029088B1

EA029088B1 EA201591456A EA201591456A EA029088B1 EA 029088 B1 EA029088 B1 EA 029088B1 EA 201591456 A EA201591456 A EA 201591456A EA 201591456 A EA201591456 A EA 201591456A EA 029088 B1 EA029088 B1 EA 029088B1

Authority

EA

Eurasian Patent Office

Prior art keywords

mmol

resulting

added

exp

lcms

Prior art date

2013-03-15

Links

• Espacenet
• Global Dossier
• Discuss

• 241000711549 Hepacivirus C Species 0.000 title claims abstract description 66
• 239000003112 inhibitor Substances 0.000 title claims abstract description 15
• 125000002619 bicyclic group Chemical group 0.000 title claims abstract 13
• 150000001875 compounds Chemical class 0.000 claims abstract description 222
• 238000000034 method Methods 0.000 claims abstract description 60
• 150000003839 salts Chemical class 0.000 claims abstract description 48
• 208000015181 infectious disease Diseases 0.000 claims abstract description 23
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 18
• 239000000203 mixture Substances 0.000 claims description 159
• 238000011282 treatment Methods 0.000 claims description 31
• 108091005804 Peptidases Proteins 0.000 claims description 24
• 239000004365 Protease Substances 0.000 claims description 24
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 19
• 230000000694 effects Effects 0.000 claims description 13
• 230000035772 mutation Effects 0.000 claims description 11
• 230000002829 reductive effect Effects 0.000 claims description 11
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 9
• 241000124008 Mammalia Species 0.000 claims description 8
• 241000700605 Viruses Species 0.000 claims description 6
• 241000282412 Homo Species 0.000 claims description 5
• 102000035195 Peptidases Human genes 0.000 claims description 5
• 239000003814 drug Substances 0.000 claims description 5
• 230000008901 benefit Effects 0.000 claims description 4
• 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 4
• 230000000840 anti-viral effect Effects 0.000 claims description 3
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims description 3
• 238000005516 engineering process Methods 0.000 claims description 3
• 230000004044 response Effects 0.000 claims description 3
• 208000006454 hepatitis Diseases 0.000 claims description 2
• 231100000283 hepatitis Toxicity 0.000 claims description 2
• 230000009467 reduction Effects 0.000 claims description 2
• 230000002269 spontaneous effect Effects 0.000 claims description 2
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 318
• 239000000543 intermediate Substances 0.000 claims 244
• 239000011541 reaction mixture Substances 0.000 claims 145
• 239000000243 solution Substances 0.000 claims 136
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 123
• 238000000132 electrospray ionisation Methods 0.000 claims 119
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims 116
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 96
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 91
• 238000002360 preparation method Methods 0.000 claims 90
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 89
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 80
• -1 acetyl AcOH Acetic acid Chemical compound 0.000 claims 79
• 239000000741 silica gel Substances 0.000 claims 70
• 229910002027 silica gel Inorganic materials 0.000 claims 70
• ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 66
• 238000004587 chromatography analysis Methods 0.000 claims 62
• OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 53
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 49
• 125000001424 substituent group Chemical group 0.000 claims 49
• 238000000746 purification Methods 0.000 claims 46
• 239000012074 organic phase Substances 0.000 claims 44
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims 44
• 239000000725 suspension Substances 0.000 claims 44
• 238000005160 1H NMR spectroscopy Methods 0.000 claims 43
• 239000012267 brine Substances 0.000 claims 43
• 125000000623 heterocyclic group Chemical group 0.000 claims 43
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 41
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 40
• 238000006243 chemical reaction Methods 0.000 claims 40
• 229920006395 saturated elastomer Polymers 0.000 claims 40
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 39
• 238000003756 stirring Methods 0.000 claims 39
• 239000007864 aqueous solution Substances 0.000 claims 36
• 125000004432 carbon atom Chemical group C* 0.000 claims 36
• 238000004128 high performance liquid chromatography Methods 0.000 claims 36
• 239000007787 solid Substances 0.000 claims 34
• 230000014759 maintenance of location Effects 0.000 claims 28
• 239000012071 phase Substances 0.000 claims 28
• 125000000217 alkyl group Chemical group 0.000 claims 26
• 125000003118 aryl group Chemical group 0.000 claims 26
• 229910052799 carbon Inorganic materials 0.000 claims 24
• 239000010410 layer Substances 0.000 claims 23
• 239000002904 solvent Substances 0.000 claims 23
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims 22
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 22
• 239000002585 base Substances 0.000 claims 22
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 22
• 125000001072 heteroaryl group Chemical group 0.000 claims 22
• 239000012044 organic layer Substances 0.000 claims 22
• 239000003153 chemical reaction reagent Substances 0.000 claims 20
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 20
• 229910052739 hydrogen Inorganic materials 0.000 claims 20
• 125000006708 (C5-C14) heteroaryl group Chemical group 0.000 claims 19
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 19
• 238000010992 reflux Methods 0.000 claims 19
• 102100037580 Sesquipedalian-1 Human genes 0.000 claims 18
• 101710169844 Sesquipedalian-1 Proteins 0.000 claims 18
• 125000004452 carbocyclyl group Chemical group 0.000 claims 18
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims 17
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 17
• 239000000872 buffer Substances 0.000 claims 17
• 229910052736 halogen Inorganic materials 0.000 claims 17
• 150000002367 halogens Chemical class 0.000 claims 17
• SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 17
• 238000005481 NMR spectroscopy Methods 0.000 claims 16
• 239000002253 acid Substances 0.000 claims 16
• 125000004429 atom Chemical group 0.000 claims 16
• 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 16
• 150000002678 macrocyclic compounds Chemical class 0.000 claims 16
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 15
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 15
• 239000004480 active ingredient Substances 0.000 claims 15
• 239000000460 chlorine Substances 0.000 claims 15
• 229910052757 nitrogen Inorganic materials 0.000 claims 15
• 239000000047 product Substances 0.000 claims 15
• 125000006239 protecting group Chemical group 0.000 claims 15
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 14
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 14
• 239000008346 aqueous phase Substances 0.000 claims 14
• 239000012300 argon atmosphere Substances 0.000 claims 14
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 13
• 229960002429 proline Drugs 0.000 claims 13
• XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims 13
• 101100520660 Drosophila melanogaster Poc1 gene Proteins 0.000 claims 12
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 12
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 12
• 101100520662 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PBA1 gene Proteins 0.000 claims 12
• 150000001336 alkenes Chemical class 0.000 claims 12
• 230000015572 biosynthetic process Effects 0.000 claims 12
• 239000001257 hydrogen Substances 0.000 claims 12
• 230000007062 hydrolysis Effects 0.000 claims 12
• 238000006460 hydrolysis reaction Methods 0.000 claims 12
• 150000003254 radicals Chemical class 0.000 claims 12
• 239000003826 tablet Substances 0.000 claims 12
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 11
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 11
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 11
• 125000003342 alkenyl group Chemical group 0.000 claims 11
• 229910052786 argon Inorganic materials 0.000 claims 11
• 239000003054 catalyst Substances 0.000 claims 11
• 239000000706 filtrate Substances 0.000 claims 11
• 125000005842 heteroatom Chemical group 0.000 claims 11
• 239000000463 material Substances 0.000 claims 11
• 239000002244 precipitate Substances 0.000 claims 11
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 11
• 238000010898 silica gel chromatography Methods 0.000 claims 11
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 11
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 11
• 229920002554 vinyl polymer Polymers 0.000 claims 11
• 125000006432 1-methyl cyclopropyl group Chemical group [H]C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 claims 10
• 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 10
• 239000012298 atmosphere Substances 0.000 claims 10
• 238000010586 diagram Methods 0.000 claims 10
• 229910052760 oxygen Inorganic materials 0.000 claims 10
• 229910052700 potassium Inorganic materials 0.000 claims 10
• 239000000126 substance Substances 0.000 claims 10
• 229910017976 MgO 4 Inorganic materials 0.000 claims 9
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 9
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 9
• 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims 9
• 150000001721 carbon Chemical group 0.000 claims 9
• 125000004043 oxo group Chemical group O=* 0.000 claims 9
• 239000011591 potassium Substances 0.000 claims 9
• 108090000623 proteins and genes Proteins 0.000 claims 9
• PBIMIGNDTBRRPI-UHFFFAOYSA-N trifluoro borate Chemical compound FOB(OF)OF PBIMIGNDTBRRPI-UHFFFAOYSA-N 0.000 claims 9
• SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims 8
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 8
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 8
• DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims 8
• 150000001241 acetals Chemical class 0.000 claims 8
• 230000003044 adaptive effect Effects 0.000 claims 8
• 239000012634 fragment Substances 0.000 claims 8
• 125000005843 halogen group Chemical group 0.000 claims 8
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 8
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 8
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 8
• 239000001301 oxygen Substances 0.000 claims 8
• 238000004007 reversed phase HPLC Methods 0.000 claims 8
• XLHFQWCMIWOPGG-UHFFFAOYSA-N 2-ethenylquinoxaline Chemical compound C1=CC=CC2=NC(C=C)=CN=C21 XLHFQWCMIWOPGG-UHFFFAOYSA-N 0.000 claims 7
• 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 7
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 7
• 125000000304 alkynyl group Chemical group 0.000 claims 7
• 238000005859 coupling reaction Methods 0.000 claims 7
• 238000009472 formulation Methods 0.000 claims 7
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 7
• 239000002609 medium Substances 0.000 claims 7
• 238000007254 oxidation reaction Methods 0.000 claims 7
• 108090000765 processed proteins & peptides Proteins 0.000 claims 7
• 102000004169 proteins and genes Human genes 0.000 claims 7
• 238000003786 synthesis reaction Methods 0.000 claims 7
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 6
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims 6
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 6
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 6
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 6
• 230000009471 action Effects 0.000 claims 6
• 230000004913 activation Effects 0.000 claims 6
• XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims 6
• 229940024606 amino acid Drugs 0.000 claims 6
• 235000001014 amino acid Nutrition 0.000 claims 6
• 150000001413 amino acids Chemical class 0.000 claims 6
• 239000013058 crude material Substances 0.000 claims 6
• 238000010511 deprotection reaction Methods 0.000 claims 6
• 150000002148 esters Chemical class 0.000 claims 6
• 230000014509 gene expression Effects 0.000 claims 6
• 229910052751 metal Inorganic materials 0.000 claims 6
• 239000002184 metal Substances 0.000 claims 6
• JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 6
• 230000003647 oxidation Effects 0.000 claims 6
• FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical compound C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 claims 6
• 150000003252 quinoxalines Chemical class 0.000 claims 6
• 239000011734 sodium Substances 0.000 claims 6
• 239000000758 substrate Substances 0.000 claims 6
• KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims 6
• 229910052717 sulfur Inorganic materials 0.000 claims 6
• 239000011593 sulfur Substances 0.000 claims 6
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 6
• 238000004809 thin layer chromatography Methods 0.000 claims 6
• 238000012546 transfer Methods 0.000 claims 6
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims 6
• ATJVVVCODTXRAE-UHFFFAOYSA-N 1-methylcyclopropane-1-sulfonamide Chemical compound NS(=O)(=O)C1(C)CC1 ATJVVVCODTXRAE-UHFFFAOYSA-N 0.000 claims 5
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 5
• 125000000041 C6-C10 aryl group Chemical group 0.000 claims 5
• LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims 5
• 239000012359 Methanesulfonyl chloride Substances 0.000 claims 5
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 5
• 150000001408 amides Chemical class 0.000 claims 5
• 150000001412 amines Chemical class 0.000 claims 5
• 239000000969 carrier Substances 0.000 claims 5
• 125000004122 cyclic group Chemical group 0.000 claims 5
• WMSPXQIQBQAWLL-UHFFFAOYSA-N cyclopropanesulfonamide Chemical compound NS(=O)(=O)C1CC1 WMSPXQIQBQAWLL-UHFFFAOYSA-N 0.000 claims 5
• 239000002552 dosage form Substances 0.000 claims 5
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
• 238000001914 filtration Methods 0.000 claims 5
• 150000002576 ketones Chemical class 0.000 claims 5
• 230000000670 limiting effect Effects 0.000 claims 5
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims 5
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
• 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 5
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 5
• 239000011148 porous material Substances 0.000 claims 5
• 238000006798 ring closing metathesis reaction Methods 0.000 claims 5
• 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 5
• 235000017557 sodium bicarbonate Nutrition 0.000 claims 5
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 5
• 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 4
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 4
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 4
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 4
• 108060001084 Luciferase Proteins 0.000 claims 4
• 239000005089 Luciferase Substances 0.000 claims 4
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims 4
• 108091027544 Subgenomic mRNA Proteins 0.000 claims 4
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 4
• 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 4
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims 4
• 229910000024 caesium carbonate Inorganic materials 0.000 claims 4
• 125000002837 carbocyclic group Chemical group 0.000 claims 4
• 239000003795 chemical substances by application Substances 0.000 claims 4
• 238000001816 cooling Methods 0.000 claims 4
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 claims 4
• 230000008878 coupling Effects 0.000 claims 4
• 238000010168 coupling process Methods 0.000 claims 4
• 125000000000 cycloalkoxy group Chemical group 0.000 claims 4
• 125000000753 cycloalkyl group Chemical group 0.000 claims 4
• 238000006704 dehydrohalogenation reaction Methods 0.000 claims 4
• 238000002474 experimental method Methods 0.000 claims 4
• 235000019253 formic acid Nutrition 0.000 claims 4
• 125000001188 haloalkyl group Chemical group 0.000 claims 4
• 239000008241 heterogeneous mixture Substances 0.000 claims 4
• 125000001183 hydrocarbyl group Chemical group 0.000 claims 4
• 239000005457 ice water Substances 0.000 claims 4
• 239000005414 inactive ingredient Substances 0.000 claims 4
• 239000004615 ingredient Substances 0.000 claims 4
• XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 4
• 239000007788 liquid Substances 0.000 claims 4
• 239000011777 magnesium Substances 0.000 claims 4
• 235000019359 magnesium stearate Nutrition 0.000 claims 4
• 238000005649 metathesis reaction Methods 0.000 claims 4
• 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
• 238000010534 nucleophilic substitution reaction Methods 0.000 claims 4
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims 4
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 claims 4
• 239000013612 plasmid Substances 0.000 claims 4
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 4
• 235000018102 proteins Nutrition 0.000 claims 4
• 238000010791 quenching Methods 0.000 claims 4
• 230000000171 quenching effect Effects 0.000 claims 4
• 239000007858 starting material Substances 0.000 claims 4
• 239000012258 stirred mixture Substances 0.000 claims 4
• 230000001225 therapeutic effect Effects 0.000 claims 4
• ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 4
• WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 claims 4
• 238000003828 vacuum filtration Methods 0.000 claims 4
• UAGFTQCWTTYZKO-WCCKRBBISA-N (2s)-pyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H]1CCCN1 UAGFTQCWTTYZKO-WCCKRBBISA-N 0.000 claims 3
• PDQRQJVPEFGVRK-UHFFFAOYSA-N 2,1,3-benzothiadiazole Chemical compound C1=CC=CC2=NSN=C21 PDQRQJVPEFGVRK-UHFFFAOYSA-N 0.000 claims 3
• 229910018072 Al 2 O 3 Inorganic materials 0.000 claims 3
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 claims 3
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 3
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
• 101100353161 Drosophila melanogaster prel gene Proteins 0.000 claims 3
• 102000004190 Enzymes Human genes 0.000 claims 3
• 108090000790 Enzymes Proteins 0.000 claims 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 3
• JIQVALKFPYXKEI-UHFFFAOYSA-N N1=CC=NC2=CC=CC=C12.[Cl] Chemical compound N1=CC=NC2=CC=CC=C12.[Cl] JIQVALKFPYXKEI-UHFFFAOYSA-N 0.000 claims 3
• 229930193140 Neomycin Natural products 0.000 claims 3
• 229920002472 Starch Polymers 0.000 claims 3
• 150000007513 acids Chemical class 0.000 claims 3
• 150000001299 aldehydes Chemical class 0.000 claims 3
• 150000001345 alkine derivatives Chemical class 0.000 claims 3
• 125000003545 alkoxy group Chemical group 0.000 claims 3
• 125000002947 alkylene group Chemical group 0.000 claims 3
• 238000004458 analytical method Methods 0.000 claims 3
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
• 239000011230 binding agent Substances 0.000 claims 3
• 230000004071 biological effect Effects 0.000 claims 3
• 230000005587 bubbling Effects 0.000 claims 3
• 239000002775 capsule Substances 0.000 claims 3
• 125000005884 carbocyclylalkyl group Chemical group 0.000 claims 3
• 150000003857 carboxamides Chemical class 0.000 claims 3
• 229910052801 chlorine Inorganic materials 0.000 claims 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
• 239000013256 coordination polymer Substances 0.000 claims 3
• 238000006880 cross-coupling reaction Methods 0.000 claims 3
• NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 claims 3
• 150000001993 dienes Chemical class 0.000 claims 3
• WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 claims 3
• 239000012039 electrophile Substances 0.000 claims 3
• 239000003480 eluent Substances 0.000 claims 3
• PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 claims 3
• 239000013604 expression vector Substances 0.000 claims 3
• 239000012065 filter cake Substances 0.000 claims 3
• 229910052731 fluorine Inorganic materials 0.000 claims 3
• 239000011521 glass Substances 0.000 claims 3
• 238000010438 heat treatment Methods 0.000 claims 3
• 208000010710 hepatitis C virus infection Diseases 0.000 claims 3
• 229910052740 iodine Inorganic materials 0.000 claims 3
• 239000008101 lactose Substances 0.000 claims 3
• 229960001375 lactose Drugs 0.000 claims 3
• GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 claims 3
• 229940040692 lithium hydroxide monohydrate Drugs 0.000 claims 3
• GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims 3
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 3
• 238000002156 mixing Methods 0.000 claims 3
• VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 claims 3
• 229960004927 neomycin Drugs 0.000 claims 3
• 230000007935 neutral effect Effects 0.000 claims 3
• 239000012299 nitrogen atmosphere Substances 0.000 claims 3
• SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 claims 3
• 239000003921 oil Substances 0.000 claims 3
• 230000003287 optical effect Effects 0.000 claims 3
• 239000000651 prodrug Substances 0.000 claims 3
• 229940002612 prodrug Drugs 0.000 claims 3
• 230000010076 replication Effects 0.000 claims 3
• 239000011780 sodium chloride Substances 0.000 claims 3
• 239000007909 solid dosage form Substances 0.000 claims 3
• 239000008107 starch Substances 0.000 claims 3
• 235000019698 starch Nutrition 0.000 claims 3
• 230000000707 stereoselective effect Effects 0.000 claims 3
• 229960002317 succinimide Drugs 0.000 claims 3
• 229940124530 sulfonamide Drugs 0.000 claims 3
• 150000003456 sulfonamides Chemical class 0.000 claims 3
• CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims 2
• 125000006528 (C2-C6) alkyl group Chemical group 0.000 claims 2
• 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
• NXGHEDHQXXXTTP-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-2-nitroethene Chemical group CSC(SC)=C[N+]([O-])=O NXGHEDHQXXXTTP-UHFFFAOYSA-N 0.000 claims 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 2
• RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 claims 2
• SPSSDDOTEZKOOV-UHFFFAOYSA-N 2,3-dichloroquinoxaline Chemical compound C1=CC=C2N=C(Cl)C(Cl)=NC2=C1 SPSSDDOTEZKOOV-UHFFFAOYSA-N 0.000 claims 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 claims 2
• VWLLPPSBBHDXHK-UHFFFAOYSA-N 3,4-diaminobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1N VWLLPPSBBHDXHK-UHFFFAOYSA-N 0.000 claims 2
• GDDNTTHUKVNJRA-UHFFFAOYSA-N 3-bromo-3,3-difluoroprop-1-ene Chemical compound FC(F)(Br)C=C GDDNTTHUKVNJRA-UHFFFAOYSA-N 0.000 claims 2
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 2
• QFMJFXFXQAFGBO-UHFFFAOYSA-N 4-methoxy-2-nitroaniline Chemical compound COC1=CC=C(N)C([N+]([O-])=O)=C1 QFMJFXFXQAFGBO-UHFFFAOYSA-N 0.000 claims 2
• SXCHMHOBHJOXGC-UHFFFAOYSA-N 4-methoxybenzene-1,2-diamine;dihydrochloride Chemical compound Cl.Cl.COC1=CC=C(N)C(N)=C1 SXCHMHOBHJOXGC-UHFFFAOYSA-N 0.000 claims 2
• LPNANKDXVBMDKE-UHFFFAOYSA-N 5-bromopent-1-ene Chemical compound BrCCCC=C LPNANKDXVBMDKE-UHFFFAOYSA-N 0.000 claims 2
• GTEUBQCAVFVWBL-UHFFFAOYSA-N 5-iodopent-1-ene Chemical compound ICCCC=C GTEUBQCAVFVWBL-UHFFFAOYSA-N 0.000 claims 2
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 2
• FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo(3.3.1)nonane Chemical compound C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 claims 2
• 101150072179 ATP1 gene Proteins 0.000 claims 2
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 2
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims 2
• 101100003366 Arabidopsis thaliana ATPA gene Proteins 0.000 claims 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
• 241000894006 Bacteria Species 0.000 claims 2
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 2
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
• 108091026890 Coding region Proteins 0.000 claims 2
• 229920002785 Croscarmellose sodium Polymers 0.000 claims 2
• 108020004414 DNA Proteins 0.000 claims 2
• OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 claims 2
• 102100021649 Elongator complex protein 6 Human genes 0.000 claims 2
• 241000710188 Encephalomyocarditis virus Species 0.000 claims 2
• 239000004593 Epoxy Substances 0.000 claims 2
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 2
• 239000005977 Ethylene Substances 0.000 claims 2
• YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 2
• 241000134307 Hepatitis C virus genotype 1 Species 0.000 claims 2
• 101100065219 Homo sapiens ELP6 gene Proteins 0.000 claims 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims 2
• 102000014150 Interferons Human genes 0.000 claims 2
• 108010050904 Interferons Proteins 0.000 claims 2
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 2
• 241001465754 Metazoa Species 0.000 claims 2
• 229920000168 Microcrystalline cellulose Polymers 0.000 claims 2
• 238000006751 Mitsunobu reaction Methods 0.000 claims 2
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
• UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 2
• 108700008625 Reporter Genes Proteins 0.000 claims 2
• 238000006932 Simmons-Smith cyclopropanation reaction Methods 0.000 claims 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
• 241000723873 Tobacco mosaic virus Species 0.000 claims 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 2
• 125000003158 alcohol group Chemical group 0.000 claims 2
• 150000001350 alkyl halides Chemical class 0.000 claims 2
• BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 claims 2
• 229940061720 alpha hydroxy acid Drugs 0.000 claims 2
• 150000001280 alpha hydroxy acids Chemical class 0.000 claims 2
• 101150105046 atpI gene Proteins 0.000 claims 2
• 238000012658 bimolecular nucleophilic substitution Methods 0.000 claims 2
• 239000007853 buffer solution Substances 0.000 claims 2
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
• 229960005069 calcium Drugs 0.000 claims 2
• 239000004202 carbamide Substances 0.000 claims 2
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 2
• 238000003776 cleavage reaction Methods 0.000 claims 2
• 238000007796 conventional method Methods 0.000 claims 2
• 229960001681 croscarmellose sodium Drugs 0.000 claims 2
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 2
• 239000012043 crude product Substances 0.000 claims 2
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
• 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
• 230000003111 delayed effect Effects 0.000 claims 2
• 150000004985 diamines Chemical class 0.000 claims 2
• 238000010790 dilution Methods 0.000 claims 2
• 239000012895 dilution Substances 0.000 claims 2
• KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims 2
• 238000006073 displacement reaction Methods 0.000 claims 2
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims 2
• 239000003937 drug carrier Substances 0.000 claims 2
• 238000001035 drying Methods 0.000 claims 2
• 238000005886 esterification reaction Methods 0.000 claims 2
• VDDXQSUSMHZCLS-UHFFFAOYSA-N ethenyl trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC=C VDDXQSUSMHZCLS-UHFFFAOYSA-N 0.000 claims 2
• 239000000284 extract Substances 0.000 claims 2
• 238000001125 extrusion Methods 0.000 claims 2
• 239000012091 fetal bovine serum Substances 0.000 claims 2
• 239000000796 flavoring agent Substances 0.000 claims 2
• 239000011737 fluorine Substances 0.000 claims 2
• 239000006260 foam Substances 0.000 claims 2
• 235000013355 food flavoring agent Nutrition 0.000 claims 2
• 125000000524 functional group Chemical group 0.000 claims 2
• 238000007429 general method Methods 0.000 claims 2
• 125000000262 haloalkenyl group Chemical group 0.000 claims 2
• GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims 2
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
• 229910052738 indium Inorganic materials 0.000 claims 2
• APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims 2
• 230000006698 induction Effects 0.000 claims 2
• 230000005764 inhibitory process Effects 0.000 claims 2
• 229940079322 interferon Drugs 0.000 claims 2
• 230000003834 intracellular effect Effects 0.000 claims 2
• 239000011630 iodine Substances 0.000 claims 2
• 150000002500 ions Chemical class 0.000 claims 2
• 238000002955 isolation Methods 0.000 claims 2
• 150000004715 keto acids Chemical class 0.000 claims 2
• 125000005647 linker group Chemical group 0.000 claims 2
• ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims 2
• 229910052749 magnesium Inorganic materials 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 239000003550 marker Substances 0.000 claims 2
• 238000001819 mass spectrum Methods 0.000 claims 2
• 150000004702 methyl esters Chemical class 0.000 claims 2
• LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 claims 2
• 230000011987 methylation Effects 0.000 claims 2
• 238000007069 methylation reaction Methods 0.000 claims 2
• 239000008108 microcrystalline cellulose Substances 0.000 claims 2
• 235000019813 microcrystalline cellulose Nutrition 0.000 claims 2
• 229940016286 microcrystalline cellulose Drugs 0.000 claims 2
• 150000007522 mineralic acids Chemical class 0.000 claims 2
• 230000004048 modification Effects 0.000 claims 2
• 238000012986 modification Methods 0.000 claims 2
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims 2
• 125000002950 monocyclic group Chemical group 0.000 claims 2
• 125000004437 phosphorous atom Chemical group 0.000 claims 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims 2
• 229910000027 potassium carbonate Inorganic materials 0.000 claims 2
• 229940069328 povidone Drugs 0.000 claims 2
• 239000000843 powder Substances 0.000 claims 2
• 239000002243 precursor Substances 0.000 claims 2
• 230000000069 prophylactic effect Effects 0.000 claims 2
• 238000011321 prophylaxis Methods 0.000 claims 2
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
• 230000001681 protective effect Effects 0.000 claims 2
• 125000002577 pseudohalo group Chemical group 0.000 claims 2
• 238000011084 recovery Methods 0.000 claims 2
• 238000007363 ring formation reaction Methods 0.000 claims 2
• FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 claims 2
• 239000012047 saturated solution Substances 0.000 claims 2
• 230000007017 scission Effects 0.000 claims 2
• 239000013049 sediment Substances 0.000 claims 2
• 238000000926 separation method Methods 0.000 claims 2
• 229910052710 silicon Inorganic materials 0.000 claims 2
• 239000010703 silicon Substances 0.000 claims 2
• 239000007790 solid phase Substances 0.000 claims 2
• 125000003003 spiro group Chemical group 0.000 claims 2
• 238000006467 substitution reaction Methods 0.000 claims 2
• 150000003460 sulfonic acids Chemical class 0.000 claims 2
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
• 230000001052 transient effect Effects 0.000 claims 2
• 229910052723 transition metal Inorganic materials 0.000 claims 2
• 150000003624 transition metals Chemical class 0.000 claims 2
• FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 claims 2
• 239000011534 wash buffer Substances 0.000 claims 2
• 238000005406 washing Methods 0.000 claims 2
• 229910052727 yttrium Inorganic materials 0.000 claims 2
• GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 claims 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims 2
• 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
• 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
• 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
• 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 1
• 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 1
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims 1
• FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 claims 1
• GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims 1
• 229940005561 1,4-benzoquinone Drugs 0.000 claims 1
• 125000005940 1,4-dioxanyl group Chemical group 0.000 claims 1
• UZKBSZSTDQSMDR-UHFFFAOYSA-N 1-[(4-chlorophenyl)-phenylmethyl]piperazine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)N1CCNCC1 UZKBSZSTDQSMDR-UHFFFAOYSA-N 0.000 claims 1
• ICFYIIFDLXRDMA-UHFFFAOYSA-N 1-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide;hydrochloride Chemical compound Cl.C1CC1S(=O)(=O)C1(C(=O)N)CC1C=C ICFYIIFDLXRDMA-UHFFFAOYSA-N 0.000 claims 1
• 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 claims 1
• 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 claims 1
• JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 claims 1
• UISKCLYHIKZGRH-UHFFFAOYSA-N 2,7-dichloro-3-prop-2-enylquinazolin-4-one Chemical compound N1=C(Cl)N(CC=C)C(=O)C=2C1=CC(Cl)=CC=2 UISKCLYHIKZGRH-UHFFFAOYSA-N 0.000 claims 1
• POSYIZJHMLBDSE-UHFFFAOYSA-N 2-chloro-6-methoxy-3-methylsulfonylquinoxaline Chemical compound N1=C(Cl)C(S(C)(=O)=O)=NC2=CC(OC)=CC=C21 POSYIZJHMLBDSE-UHFFFAOYSA-N 0.000 claims 1
• ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims 1
• JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims 1
• QZVQQUVWFIZUBQ-UHFFFAOYSA-N 3-fluoroaniline Chemical compound NC1=CC=CC(F)=C1 QZVQQUVWFIZUBQ-UHFFFAOYSA-N 0.000 claims 1
• IGPFOKFDBICQMC-UHFFFAOYSA-N 3-phenylmethoxyaniline Chemical compound NC1=CC=CC(OCC=2C=CC=CC=2)=C1 IGPFOKFDBICQMC-UHFFFAOYSA-N 0.000 claims 1
• PRCYIYOCMALJCX-UHFFFAOYSA-N 4,4-diethoxybut-1-ene Chemical compound CCOC(CC=C)OCC PRCYIYOCMALJCX-UHFFFAOYSA-N 0.000 claims 1
• PPWRHKISAQTCCG-UHFFFAOYSA-N 4,5-difluorobenzene-1,2-diamine Chemical compound NC1=CC(F)=C(F)C=C1N PPWRHKISAQTCCG-UHFFFAOYSA-N 0.000 claims 1
• GRBDLKBKKHPPQX-UHFFFAOYSA-N 4-(difluoromethoxy)benzene-1,2-diamine Chemical compound NC1=CC=C(OC(F)F)C=C1N GRBDLKBKKHPPQX-UHFFFAOYSA-N 0.000 claims 1
• QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 1
• QEHVRGACCVLLNN-UHFFFAOYSA-N 5-methoxy-2-nitroaniline Chemical compound COC1=CC=C([N+]([O-])=O)C(N)=C1 QEHVRGACCVLLNN-UHFFFAOYSA-N 0.000 claims 1
• 102100035767 Adrenocortical dysplasia protein homolog Human genes 0.000 claims 1
• WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims 1
• 101100404726 Arabidopsis thaliana NHX7 gene Proteins 0.000 claims 1
• 102220495975 BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like_N84A_mutation Human genes 0.000 claims 1
• ZETHHMPKDUSZQQ-UHFFFAOYSA-N Betulafolienepentol Natural products C1C=C(C)CCC(C(C)CCC=C(C)C)C2C(OC)OC(OC)C2=C1 ZETHHMPKDUSZQQ-UHFFFAOYSA-N 0.000 claims 1
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 claims 1
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
• 239000004215 Carbon black (E152) Substances 0.000 claims 1
• PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 claims 1
• 238000005750 Corey-Bakshi-Shibata reduction reaction Methods 0.000 claims 1
• 229920002261 Corn starch Polymers 0.000 claims 1
• 244000304337 Cuminum cyminum Species 0.000 claims 1
• 235000007129 Cuminum cyminum Nutrition 0.000 claims 1
• 108010002156 Depsipeptides Proteins 0.000 claims 1
• 238000006646 Dess-Martin oxidation reaction Methods 0.000 claims 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 1
• 229920001353 Dextrin Polymers 0.000 claims 1
• 239000004375 Dextrin Substances 0.000 claims 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
• 239000006145 Eagle's minimal essential medium Substances 0.000 claims 1
• 102100027094 Echinoderm microtubule-associated protein-like 1 Human genes 0.000 claims 1
• 241000991587 Enterovirus C Species 0.000 claims 1
• 230000005526 G1 to G0 transition Effects 0.000 claims 1
• 108010010803 Gelatin Proteins 0.000 claims 1
• 239000007818 Grignard reagent Substances 0.000 claims 1
• 229910004373 HOAc Inorganic materials 0.000 claims 1
• 208000005176 Hepatitis C Diseases 0.000 claims 1
• 241001093325 Hepatitis C virus genotype 3 Species 0.000 claims 1
• 241001466980 Hepatitis C virus genotype 4 Species 0.000 claims 1
• 241001466982 Hepatitis C virus genotype 5 Species 0.000 claims 1
• 241000143279 Hepatitis C virus genotype 6 Species 0.000 claims 1
• 101100433963 Homo sapiens ACD gene Proteins 0.000 claims 1
• 101001057941 Homo sapiens Echinoderm microtubule-associated protein-like 1 Proteins 0.000 claims 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
• SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 1
• 229930064664 L-arginine Natural products 0.000 claims 1
• 235000014852 L-arginine Nutrition 0.000 claims 1
• VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 claims 1
• 239000002841 Lewis acid Substances 0.000 claims 1
• 235000019759 Maize starch Nutrition 0.000 claims 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 claims 1
• 108060004795 Methyltransferase Proteins 0.000 claims 1
• 229920000881 Modified starch Polymers 0.000 claims 1
• 101100189356 Mus musculus Papolb gene Proteins 0.000 claims 1
• 101000653787 Mus musculus Protein S100-A11 Proteins 0.000 claims 1
• JRNVZBWKYDBUCA-UHFFFAOYSA-N N-Chlorosuccinimide Substances ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims 1
• NSGDYZCDUPSTQT-UHFFFAOYSA-N N-[5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxopyridin-3-yl]cycloheptanecarboxamide Chemical compound Cc1c(Br)cn(Cc2ccc(F)cc2)c(=O)c1NC(=O)C1CCCCCC1 NSGDYZCDUPSTQT-UHFFFAOYSA-N 0.000 claims 1
• ZVROPCXDPUEDAG-UHFFFAOYSA-N NO.NSO Chemical compound NO.NSO ZVROPCXDPUEDAG-UHFFFAOYSA-N 0.000 claims 1
• 101100341115 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ipp-1 gene Proteins 0.000 claims 1
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 1
• 208000009989 Posterior Leukoencephalopathy Syndrome Diseases 0.000 claims 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 1
• 101000932966 Pseudomonas aeruginosa CD-NTase-associated protein 8 Proteins 0.000 claims 1
• 101100273635 Rattus norvegicus Ccn5 gene Proteins 0.000 claims 1
• 241000283984 Rodentia Species 0.000 claims 1
• 108700022176 SOS1 Proteins 0.000 claims 1
• 101100197320 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RPL35A gene Proteins 0.000 claims 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
• 239000005708 Sodium hypochlorite Substances 0.000 claims 1
• 102100032929 Son of sevenless homolog 1 Human genes 0.000 claims 1
• 101150100839 Sos1 gene Proteins 0.000 claims 1
• 235000021355 Stearic acid Nutrition 0.000 claims 1
• PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 claims 1
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
• UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims 1
• QYTDEUPAUMOIOP-UHFFFAOYSA-N TEMPO Chemical group CC1(C)CCCC(C)(C)N1[O] QYTDEUPAUMOIOP-UHFFFAOYSA-N 0.000 claims 1
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 claims 1
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims 1
• 229910052770 Uranium Inorganic materials 0.000 claims 1
• HVVNJUAVDAZWCB-YFKPBYRVSA-N [(2s)-pyrrolidin-2-yl]methanol Chemical compound OC[C@@H]1CCCN1 HVVNJUAVDAZWCB-YFKPBYRVSA-N 0.000 claims 1
• REAYFGLASQTHKB-UHFFFAOYSA-N [2-[3-(1H-pyrazol-4-yl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound N1N=CC(=C1)C=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 REAYFGLASQTHKB-UHFFFAOYSA-N 0.000 claims 1
• LHTUYNSQNJOCCB-UHFFFAOYSA-M [Br-].[Mg+]CCCC=C Chemical compound [Br-].[Mg+]CCCC=C LHTUYNSQNJOCCB-UHFFFAOYSA-M 0.000 claims 1
• IUHFWCGCSVTMPG-UHFFFAOYSA-N [C].[C] Chemical class [C].[C] IUHFWCGCSVTMPG-UHFFFAOYSA-N 0.000 claims 1
• 238000010521 absorption reaction Methods 0.000 claims 1
• AUALQMFGWLZREY-UHFFFAOYSA-N acetonitrile;methanol Chemical compound OC.CC#N AUALQMFGWLZREY-UHFFFAOYSA-N 0.000 claims 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
• 230000002378 acidificating effect Effects 0.000 claims 1
• 230000003213 activating effect Effects 0.000 claims 1
• 239000011149 active material Substances 0.000 claims 1
• 239000013543 active substance Substances 0.000 claims 1
• 239000000654 additive Substances 0.000 claims 1
• 239000002671 adjuvant Substances 0.000 claims 1
• 150000001298 alcohols Chemical class 0.000 claims 1
• 239000000783 alginic acid Substances 0.000 claims 1
• 235000010443 alginic acid Nutrition 0.000 claims 1
• 229920000615 alginic acid Polymers 0.000 claims 1
• 229960001126 alginic acid Drugs 0.000 claims 1
• 150000004781 alginic acids Chemical class 0.000 claims 1
• 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
• 229910052783 alkali metal Inorganic materials 0.000 claims 1
• 150000001340 alkali metals Chemical class 0.000 claims 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
• 150000001342 alkaline earth metals Chemical class 0.000 claims 1
• 125000004450 alkenylene group Chemical group 0.000 claims 1
• 150000001347 alkyl bromides Chemical class 0.000 claims 1
• 125000005466 alkylenyl group Chemical group 0.000 claims 1
• 125000004419 alkynylene group Chemical group 0.000 claims 1
• 238000005937 allylation reaction Methods 0.000 claims 1
• 150000004716 alpha keto acids Chemical class 0.000 claims 1
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
• 125000003277 amino group Chemical group 0.000 claims 1
• 229910021529 ammonia Inorganic materials 0.000 claims 1
• 235000019270 ammonium chloride Nutrition 0.000 claims 1
• 150000001450 anions Chemical class 0.000 claims 1
• 239000003963 antioxidant agent Substances 0.000 claims 1
• 235000006708 antioxidants Nutrition 0.000 claims 1
• 239000007900 aqueous suspension Substances 0.000 claims 1
• 238000010936 aqueous wash Methods 0.000 claims 1
• 150000001543 aryl boronic acids Chemical class 0.000 claims 1
• 150000001502 aryl halides Chemical class 0.000 claims 1
• 125000000732 arylene group Chemical group 0.000 claims 1
• 235000010323 ascorbic acid Nutrition 0.000 claims 1
• 229960005070 ascorbic acid Drugs 0.000 claims 1
• 239000011668 ascorbic acid Substances 0.000 claims 1
• 238000003556 assay Methods 0.000 claims 1
• 125000002393 azetidinyl group Chemical group 0.000 claims 1
• 230000009286 beneficial effect Effects 0.000 claims 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
• 125000005872 benzooxazolyl group Chemical group 0.000 claims 1
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
• 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 1
• HFCMQKFXCMZZMZ-UHFFFAOYSA-N bicyclo[3.1.0]hexan-2-one Chemical compound O=C1CCC2CC12 HFCMQKFXCMZZMZ-UHFFFAOYSA-N 0.000 claims 1
• YKXMZSYOSBDLMM-UHFFFAOYSA-N bicyclo[3.1.0]hexan-3-ol Chemical compound C1C(O)CC2CC21 YKXMZSYOSBDLMM-UHFFFAOYSA-N 0.000 claims 1
• PMAXNHPFNDQMAO-UHFFFAOYSA-N bicyclo[3.1.1]heptan-4-one Chemical compound O=C1CCC2CC1C2 PMAXNHPFNDQMAO-UHFFFAOYSA-N 0.000 claims 1
• 230000003115 biocidal effect Effects 0.000 claims 1
• 239000012455 biphasic mixture Substances 0.000 claims 1
• 238000009835 boiling Methods 0.000 claims 1
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
• 229910052794 bromium Inorganic materials 0.000 claims 1
• 239000006227 byproduct Substances 0.000 claims 1
• VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 1
• 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
• 239000001506 calcium phosphate Substances 0.000 claims 1
• 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
• 235000011010 calcium phosphates Nutrition 0.000 claims 1
• JJNHBFYGCSOONU-UHFFFAOYSA-M carbanide;cyclopenta-1,3-diene;dimethylaluminum;titanium(4+);chloride Chemical compound [CH3-].[Ti+3]Cl.C[Al]C.C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 JJNHBFYGCSOONU-UHFFFAOYSA-M 0.000 claims 1
• 150000001720 carbohydrates Chemical class 0.000 claims 1
• 235000014633 carbohydrates Nutrition 0.000 claims 1
• 150000001735 carboxylic acids Chemical class 0.000 claims 1
• 239000012876 carrier material Substances 0.000 claims 1
• 238000006555 catalytic reaction Methods 0.000 claims 1
• 150000001768 cations Chemical class 0.000 claims 1
• 239000013592 cell lysate Substances 0.000 claims 1
• 239000006285 cell suspension Substances 0.000 claims 1
• 238000005119 centrifugation Methods 0.000 claims 1
• 239000002738 chelating agent Substances 0.000 claims 1
• 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 claims 1
• 239000012230 colorless oil Substances 0.000 claims 1
• 238000004440 column chromatography Methods 0.000 claims 1
• 229940125898 compound 5 Drugs 0.000 claims 1
• 239000012050 conventional carrier Substances 0.000 claims 1
• 239000007822 coupling agent Substances 0.000 claims 1
• 238000006352 cycloaddition reaction Methods 0.000 claims 1
• 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
• 125000002993 cycloalkylene group Chemical group 0.000 claims 1
• 125000004976 cyclobutylene group Chemical group 0.000 claims 1
• 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims 1
• 125000004956 cyclohexylene group Chemical group 0.000 claims 1
• ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 claims 1
• 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 claims 1
• 125000004979 cyclopentylene group Chemical group 0.000 claims 1
• 125000004980 cyclopropylene group Chemical group 0.000 claims 1
• 230000003247 decreasing effect Effects 0.000 claims 1
• 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
• 238000007872 degassing Methods 0.000 claims 1
• 238000001514 detection method Methods 0.000 claims 1
• 229910052805 deuterium Inorganic materials 0.000 claims 1
• 235000019425 dextrin Nutrition 0.000 claims 1
• HEOKFDGOFROELJ-UHFFFAOYSA-N diacetal Natural products COc1ccc(C=C/c2cc(O)cc(OC3OC(COC(=O)c4cc(O)c(O)c(O)c4)C(O)C(O)C3O)c2)cc1O HEOKFDGOFROELJ-UHFFFAOYSA-N 0.000 claims 1
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
• CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 claims 1
• HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 claims 1
• 125000006001 difluoroethyl group Chemical group 0.000 claims 1
• 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 1
• 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 claims 1
• 125000005435 dihydrobenzoxazolyl group Chemical group O1C(NC2=C1C=CC=C2)* 0.000 claims 1
• 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 claims 1
• 125000001070 dihydroindolyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 1
• 125000005048 dihydroisoxazolyl group Chemical group O1N(CC=C1)* 0.000 claims 1
• 125000005049 dihydrooxadiazolyl group Chemical group O1N(NC=C1)* 0.000 claims 1
• 125000005050 dihydrooxazolyl group Chemical group O1C(NC=C1)* 0.000 claims 1
• 125000005051 dihydropyrazinyl group Chemical group N1(CC=NC=C1)* 0.000 claims 1
• 125000005052 dihydropyrazolyl group Chemical group N1(NCC=C1)* 0.000 claims 1
• 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 claims 1
• 125000005053 dihydropyrimidinyl group Chemical group N1(CN=CC=C1)* 0.000 claims 1
• 125000005054 dihydropyrrolyl group Chemical group [H]C1=C([H])C([H])([H])C([H])([H])N1* 0.000 claims 1
• 125000005056 dihydrothiazolyl group Chemical group S1C(NC=C1)* 0.000 claims 1
• 125000005057 dihydrothienyl group Chemical group S1C(CC=C1)* 0.000 claims 1
• 239000003085 diluting agent Substances 0.000 claims 1
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
• 229910000397 disodium phosphate Inorganic materials 0.000 claims 1
• 235000019800 disodium phosphate Nutrition 0.000 claims 1
• 238000004090 dissolution Methods 0.000 claims 1
• 238000004821 distillation Methods 0.000 claims 1
• GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 claims 1
• CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 claims 1
• 229940079593 drug Drugs 0.000 claims 1
• 238000004520 electroporation Methods 0.000 claims 1
• 239000000839 emulsion Substances 0.000 claims 1
• 238000011067 equilibration Methods 0.000 claims 1
• 125000004185 ester group Chemical group 0.000 claims 1
• 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 claims 1
• HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 claims 1
• YLRYFGJQTOKMSD-UHFFFAOYSA-N ethyl 3,3-difluoro-2,2-dihydroxypent-4-enoate Chemical compound CCOC(=O)C(O)(O)C(F)(F)C=C YLRYFGJQTOKMSD-UHFFFAOYSA-N 0.000 claims 1
• DBPFRRFGLYGEJI-UHFFFAOYSA-N ethyl glyoxylate Chemical compound CCOC(=O)C=O DBPFRRFGLYGEJI-UHFFFAOYSA-N 0.000 claims 1
• 238000011156 evaluation Methods 0.000 claims 1
• 230000005284 excitation Effects 0.000 claims 1
• 238000000605 extraction Methods 0.000 claims 1
• 239000000945 filler Substances 0.000 claims 1
• 238000004334 fluoridation Methods 0.000 claims 1
• 235000003599 food sweetener Nutrition 0.000 claims 1
• 239000012458 free base Substances 0.000 claims 1
• 239000012737 fresh medium Substances 0.000 claims 1
• 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
• 239000008273 gelatin Substances 0.000 claims 1
• 229920000159 gelatin Polymers 0.000 claims 1
• 235000019322 gelatine Nutrition 0.000 claims 1
• 235000011852 gelatine desserts Nutrition 0.000 claims 1
• 235000021472 generally recognized as safe Nutrition 0.000 claims 1
• 229940074045 glyceryl distearate Drugs 0.000 claims 1
• 229940075507 glyceryl monostearate Drugs 0.000 claims 1
• 125000003827 glycol group Chemical group 0.000 claims 1
• HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 claims 1
• 239000008187 granular material Substances 0.000 claims 1
• 150000004795 grignard reagents Chemical class 0.000 claims 1
• 229920000591 gum Polymers 0.000 claims 1
• 125000004438 haloalkoxy group Chemical group 0.000 claims 1
• 230000026030 halogenation Effects 0.000 claims 1
• 238000005658 halogenation reaction Methods 0.000 claims 1
• 239000007902 hard capsule Substances 0.000 claims 1
• 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
• 125000004404 heteroalkyl group Chemical group 0.000 claims 1
• 125000004474 heteroalkylene group Chemical group 0.000 claims 1
• 125000005549 heteroarylene group Chemical group 0.000 claims 1
• 150000004677 hydrates Chemical class 0.000 claims 1
• 229930195733 hydrocarbon Natural products 0.000 claims 1
• 150000002430 hydrocarbons Chemical class 0.000 claims 1
• 150000002431 hydrogen Chemical class 0.000 claims 1
• 230000002209 hydrophobic effect Effects 0.000 claims 1
• 150000001261 hydroxy acids Chemical class 0.000 claims 1
• 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
• 125000002883 imidazolyl group Chemical group 0.000 claims 1
• 239000012535 impurity Substances 0.000 claims 1
• 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
• 239000003701 inert diluent Substances 0.000 claims 1
• 230000002401 inhibitory effect Effects 0.000 claims 1
• 239000007924 injection Substances 0.000 claims 1
• 238000002347 injection Methods 0.000 claims 1
• 239000002198 insoluble material Substances 0.000 claims 1
• 238000007918 intramuscular administration Methods 0.000 claims 1
• 238000007913 intrathecal administration Methods 0.000 claims 1
• 238000001990 intravenous administration Methods 0.000 claims 1
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
• 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
• 230000000155 isotopic effect Effects 0.000 claims 1
• 125000003971 isoxazolinyl group Chemical group 0.000 claims 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims 1
• 229960000318 kanamycin Drugs 0.000 claims 1
• 229930027917 kanamycin Natural products 0.000 claims 1
• 229930182823 kanamycin A Natural products 0.000 claims 1
• 229960001021 lactose monohydrate Drugs 0.000 claims 1
• 208000025766 lethal multiple pterygium syndrome Diseases 0.000 claims 1
• 150000007517 lewis acids Chemical class 0.000 claims 1
• 238000012417 linear regression Methods 0.000 claims 1
• YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 claims 1
• 210000004185 liver Anatomy 0.000 claims 1
• 239000007937 lozenge Substances 0.000 claims 1
• 239000000314 lubricant Substances 0.000 claims 1
• 239000006166 lysate Substances 0.000 claims 1
• 239000012139 lysis buffer Substances 0.000 claims 1
• 230000002101 lytic effect Effects 0.000 claims 1
• 108010026228 mRNA guanylyltransferase Proteins 0.000 claims 1
• OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 claims 1
• 229910001623 magnesium bromide Inorganic materials 0.000 claims 1
• 238000004949 mass spectrometry Methods 0.000 claims 1
• 238000005259 measurement Methods 0.000 claims 1
• 229950002475 mesilate Drugs 0.000 claims 1
• 230000002503 metabolic effect Effects 0.000 claims 1
• 229910000000 metal hydroxide Inorganic materials 0.000 claims 1
• 150000004692 metal hydroxides Chemical class 0.000 claims 1
• MMSKTMKTGVHMAV-UHFFFAOYSA-N methyl 2-ethenyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopropane-1-carboxylate Chemical compound CC(C)(C)OC(=O)NC1(C(=O)OC)CC1C=C MMSKTMKTGVHMAV-UHFFFAOYSA-N 0.000 claims 1
• 125000006431 methyl cyclopropyl group Chemical group 0.000 claims 1
• 239000003607 modifier Substances 0.000 claims 1
• 229940045641 monobasic sodium phosphate Drugs 0.000 claims 1
• 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
• 235000019799 monosodium phosphate Nutrition 0.000 claims 1
• 125000002757 morpholinyl group Chemical group 0.000 claims 1
• PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 claims 1
• RNQOJAOHKRAEST-UHFFFAOYSA-N n-cyclopropylsulfonyl-2-ethenylcyclopropane-1-carboxamide;hydrochloride Chemical compound Cl.C=CC1CC1C(=O)NS(=O)(=O)C1CC1 RNQOJAOHKRAEST-UHFFFAOYSA-N 0.000 claims 1
• 125000001624 naphthyl group Chemical group 0.000 claims 1
• 125000004957 naphthylene group Chemical group 0.000 claims 1
• 239000013642 negative control Substances 0.000 claims 1
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
• RPMXALUWKZHYOV-UHFFFAOYSA-N nitroethene Chemical compound [O-][N+](=O)C=C RPMXALUWKZHYOV-UHFFFAOYSA-N 0.000 claims 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
• 125000006574 non-aromatic ring group Chemical group 0.000 claims 1
• 231100000252 nontoxic Toxicity 0.000 claims 1
• 230000003000 nontoxic effect Effects 0.000 claims 1
• 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
• 238000010899 nucleation Methods 0.000 claims 1
• 239000012038 nucleophile Substances 0.000 claims 1
• 239000002777 nucleoside Substances 0.000 claims 1
• 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
• TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
• 238000006772 olefination reaction Methods 0.000 claims 1
• 239000006186 oral dosage form Substances 0.000 claims 1
• 150000007524 organic acids Chemical class 0.000 claims 1
• 125000002524 organometallic group Chemical group 0.000 claims 1
• 125000005968 oxazolinyl group Chemical group 0.000 claims 1
• 125000003566 oxetanyl group Chemical group 0.000 claims 1
• 230000001590 oxidative effect Effects 0.000 claims 1
• 238000007248 oxidative elimination reaction Methods 0.000 claims 1
• 125000004430 oxygen atom Chemical group O* 0.000 claims 1
• 125000005489 p-toluenesulfonic acid group Chemical class 0.000 claims 1
• 229910052763 palladium Inorganic materials 0.000 claims 1
• MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 claims 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 1
• 239000003208 petroleum Substances 0.000 claims 1
• 230000004526 pharmaceutical effect Effects 0.000 claims 1
• 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
• 239000000825 pharmaceutical preparation Substances 0.000 claims 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
• 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
• 235000011007 phosphoric acid Nutrition 0.000 claims 1
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 1
• 238000006303 photolysis reaction Methods 0.000 claims 1
• 230000015843 photosynthesis, light reaction Effects 0.000 claims 1
• 230000001766 physiological effect Effects 0.000 claims 1
• 239000013641 positive control Substances 0.000 claims 1
• 235000011056 potassium acetate Nutrition 0.000 claims 1
• 238000001556 precipitation Methods 0.000 claims 1
• 238000002953 preparative HPLC Methods 0.000 claims 1
• 239000003755 preservative agent Substances 0.000 claims 1
• 230000008569 process Effects 0.000 claims 1
• 238000012545 processing Methods 0.000 claims 1
• 150000003147 proline derivatives Chemical class 0.000 claims 1
• 230000000644 propagated effect Effects 0.000 claims 1
• 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
• QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
• 238000001742 protein purification Methods 0.000 claims 1
• 239000012460 protein solution Substances 0.000 claims 1
• 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 1
• 125000003373 pyrazinyl group Chemical group 0.000 claims 1
• 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
• 238000004445 quantitative analysis Methods 0.000 claims 1
• 125000001453 quaternary ammonium group Chemical group 0.000 claims 1
• IBBLRJGOOANPTQ-JKVLGAQCSA-N quinapril hydrochloride Chemical compound Cl.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C2C1)C(O)=O)CC1=CC=CC=C1 IBBLRJGOOANPTQ-JKVLGAQCSA-N 0.000 claims 1
• APSYYKGWNWKKOC-UHFFFAOYSA-N quinoxaline-5-carboxamide Chemical compound C1=CN=C2C(C(=O)N)=CC=CC2=N1 APSYYKGWNWKKOC-UHFFFAOYSA-N 0.000 claims 1
• 230000035484 reaction time Effects 0.000 claims 1
• 238000001953 recrystallisation Methods 0.000 claims 1
• 238000006722 reduction reaction Methods 0.000 claims 1
• 230000001105 regulatory effect Effects 0.000 claims 1
• 238000011160 research Methods 0.000 claims 1
• 239000011347 resin Substances 0.000 claims 1
• 229920005989 resin Polymers 0.000 claims 1
• 238000012340 reverse transcriptase PCR Methods 0.000 claims 1
• 230000002441 reversible effect Effects 0.000 claims 1
• 125000006413 ring segment Chemical group 0.000 claims 1
• OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 claims 1
• 229910052701 rubidium Inorganic materials 0.000 claims 1
• 238000012216 screening Methods 0.000 claims 1
• 238000013207 serial dilution Methods 0.000 claims 1
• 210000002966 serum Anatomy 0.000 claims 1
• 238000007493 shaping process Methods 0.000 claims 1
• 238000002741 site-directed mutagenesis Methods 0.000 claims 1
• 229910052708 sodium Inorganic materials 0.000 claims 1
• WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 claims 1
• 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
• 229940001593 sodium carbonate Drugs 0.000 claims 1
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 1
• 229940023144 sodium glycolate Drugs 0.000 claims 1
• SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims 1
• 239000001488 sodium phosphate Substances 0.000 claims 1
• 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
• 229960003339 sodium phosphate Drugs 0.000 claims 1
• 235000011008 sodium phosphates Nutrition 0.000 claims 1
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims 1
• 235000019345 sodium thiosulphate Nutrition 0.000 claims 1
• 239000007901 soft capsule Substances 0.000 claims 1
• 230000003381 solubilizing effect Effects 0.000 claims 1
• 238000001228 spectrum Methods 0.000 claims 1
• 239000008117 stearic acid Substances 0.000 claims 1
• 239000008174 sterile solution Substances 0.000 claims 1
• 238000007920 subcutaneous administration Methods 0.000 claims 1
• 235000011044 succinic acid Nutrition 0.000 claims 1
• 150000003444 succinic acids Chemical class 0.000 claims 1
• IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 claims 1
• 150000003871 sulfonates Chemical class 0.000 claims 1
• 150000003457 sulfones Chemical class 0.000 claims 1
• 235000011149 sulphuric acid Nutrition 0.000 claims 1
• 239000006228 supernatant Substances 0.000 claims 1
• 239000003765 sweetening agent Substances 0.000 claims 1
• 239000006188 syrup Substances 0.000 claims 1
• 235000020357 syrup Nutrition 0.000 claims 1
• 239000000454 talc Substances 0.000 claims 1
• 235000012222 talc Nutrition 0.000 claims 1
• 229910052623 talc Inorganic materials 0.000 claims 1
• 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
• 238000012360 testing method Methods 0.000 claims 1
• WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 claims 1
• 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims 1
• 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
• 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims 1
• 125000005958 tetrahydrothienyl group Chemical group 0.000 claims 1
• 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 claims 1
• 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
• 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 claims 1
• OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 claims 1
• WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 claims 1
• 229940124597 therapeutic agent Drugs 0.000 claims 1
• 150000003568 thioethers Chemical class 0.000 claims 1
• 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
• 238000004448 titration Methods 0.000 claims 1
• 230000000699 topical effect Effects 0.000 claims 1
• 231100000331 toxic Toxicity 0.000 claims 1
• 230000002588 toxic effect Effects 0.000 claims 1
• 125000006168 tricyclic group Chemical group 0.000 claims 1
• KAKQVSNHTBLJCH-UHFFFAOYSA-N trifluoromethanesulfonimidic acid Chemical compound NS(=O)(=O)C(F)(F)F KAKQVSNHTBLJCH-UHFFFAOYSA-N 0.000 claims 1
• 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 claims 1
• 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
• LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 1
• 229910000404 tripotassium phosphate Inorganic materials 0.000 claims 1
• 235000019798 tripotassium phosphate Nutrition 0.000 claims 1
• YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims 1
• JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 claims 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
• 238000001665 trituration Methods 0.000 claims 1
• 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
• 229910052721 tungsten Inorganic materials 0.000 claims 1
• 230000009385 viral infection Effects 0.000 claims 1
• 239000008215 water for injection Substances 0.000 claims 1
• UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical group CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 claims 1
• 239000003443 antiviral agent Substances 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 3
• 230000003612 virological effect Effects 0.000 description 3
• IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical class N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• CZPRKINNVBONSF-UHFFFAOYSA-M zinc;dioxido(oxo)phosphanium Chemical compound [Zn+2].[O-][P+]([O-])=O CZPRKINNVBONSF-UHFFFAOYSA-M 0.000 description 2
• 229940122604 HCV protease inhibitor Drugs 0.000 description 1
• 102000006992 Interferon-alpha Human genes 0.000 description 1
• 108010047761 Interferon-alpha Proteins 0.000 description 1
• 206010034133 Pathogen resistance Diseases 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• 229960000517 boceprevir Drugs 0.000 description 1
• LHHCSNFAOIFYRV-DOVBMPENSA-N boceprevir Chemical compound O=C([C@@H]1[C@@H]2[C@@H](C2(C)C)CN1C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C)NC(C(=O)C(N)=O)CC1CCC1 LHHCSNFAOIFYRV-DOVBMPENSA-N 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 229940127073 nucleoside analogue Drugs 0.000 description 1
• 229960000329 ribavirin Drugs 0.000 description 1
• HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 229960002935 telaprevir Drugs 0.000 description 1
• BBAWEDCPNXPBQM-GDEBMMAJSA-N telaprevir Chemical compound N([C@H](C(=O)N[C@H](C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1)C(C)(C)C)C1CCCCC1)C(=O)C1=CN=CC=N1 BBAWEDCPNXPBQM-GDEBMMAJSA-N 0.000 description 1
• 108010017101 telaprevir Proteins 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1